Literature DB >> 25468222

Epidemiology of gliomas.

Quinn T Ostrom1, Haley Gittleman, Lindsay Stetson, Selene M Virk, Jill S Barnholtz-Sloan.   

Abstract

Gliomas are the most common type of primary intracranial tumors. Some glioma subtypes cause significant mortality and morbidity that are disproportionate to their relatively rare incidence. A very small proportion of glioma cases can be attributed to inherited genetic disorders. Many potential risk factors for glioma have been studied to date, but few provide explanation for the number of brain tumors identified. The most significant of these factors includes increased risk due to exposure to ionizing radiation, and decreased risk with history of allergy or atopic disease. The potential effect of exposure to cellular phones has been studied extensively, but the results remain inconclusive. Recent genomic analyses, using the genome-wide association study (GWAS) design, have identified several inherited risk variants that are associated with increased glioma risk. The following chapter provides an overview of the current state of research in the epidemiology of intracranial glioma.

Entities:  

Mesh:

Year:  2015        PMID: 25468222     DOI: 10.1007/978-3-319-12048-5_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  135 in total

1.  Post-gadolinium 3-dimensional spatial, surface, and structural characteristics of glioblastomas differentiate pseudoprogression from true tumor progression.

Authors:  Madison R Hansen; Edward Pan; Andrew Wilson; Morgan McCreary; Yeqi Wang; Thomas Stanley; Marco C Pinho; Xiaohu Guo; Darin T Okuda
Journal:  J Neurooncol       Date:  2018-06-07       Impact factor: 4.130

2.  Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis.

Authors:  Y Liu; X Xu; L Yin; X Zhang; L Li; H Lu
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-29       Impact factor: 3.825

Review 3.  Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations.

Authors:  Cristina Prieto; Isabel Linares
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-06

4.  Differential and kinetic effects of cell cycle inhibitors on neoplastic and primary astrocytes.

Authors:  Veetai Li; Thomas J Langan; Kyla R Rodgers; Richard C Chou
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

5.  TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.

Authors:  Yufu Zhu; Yang Xu; Tianze Chen; Yujian Zhang; Qiang Ma; Sunil Rauniyar; Lei Wang; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

6.  How treatment monitoring is influencing treatment decisions in glioblastomas.

Authors:  Martha R Neagu; Raymond Y Huang; David A Reardon; Patrick Y Wen
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

7.  Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Authors:  Birthe Krogh Rasmussen; Steinbjørn Hansen; René J Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2017-08-31       Impact factor: 4.130

8.  Does risk of brain cancer increase with intracranial volume? A population-based case control study.

Authors:  Even Hovig Fyllingen; Tor Ivar Hansen; Asgeir Store Jakola; Asta Kristine Håberg; Øyvind Salvesen; Ole Solheim
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

9.  PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.

Authors:  Alice Gaudin; Eric Song; Amanda R King; Jennifer K Saucier-Sawyer; Ranjit Bindra; Didier Desmaële; Patrick Couvreur; W Mark Saltzman
Journal:  Biomaterials       Date:  2016-08-04       Impact factor: 12.479

10.  The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium.

Authors:  E Susan Amirian; Georgina N Armstrong; Renke Zhou; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Michael E Scheurer; Kenneth Aldape; Irina Alafuzoff; Thomas Brännström; Helle Broholm; Peter Collins; Caterina Giannini; Marc Rosenblum; Tarik Tihan; Beatrice S Melin; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2015-12-10       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.